This section of the website is for patients who have been prescribed Cabometyx® (cabozantinib) in Ireland. Information for members of the general public can be found here.
Side effects reporting information is available at the bottom of this webpage.

This website has been commissioned by Ipsen Pharmaceuticals Ltd. and is intended for an Irish audience

All materials

A Patient’s Guide to Side Effect Management

Renal Cell Carcinoma File
19 pages

During your treatment with Cabometyx®, you may experience some side effects. Some side effects can be more common than others and you might not experience any at all. If you have any questions around side effects, please reach out to your healthcare team.

This resources aims to support you during your treatment journey by explaining any side effects you may encounter and providing tips on how to manage them.

CMX-IE-000761 | August 2025

A Patient’s Guide to Side Effect Management
Explore more Renal Cell Carcinoma Patient Support

Explore more Renal Cell Carcinoma Patient Support

Browse

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to the HPRA. Reporting forms and information can be found at www.hpra.ie or email medsafety@hpra.ie. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256. By reporting side effects, you can help provide more information on the safety of this medicine.

To access relevant information about Renal Cell Carcinoma, please choose one of the following options:

I am a healthcare professional in Ireland

This section is for healthcare professionals only. Contains promotional information

I am a healthcare professional in Ireland

Adverse events should be reported.
Reporting forms and information can be found at www.hpra.ie or e-mail medsafety@hpra.ie.
The HPRA can also be contacted on +353 16764971. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256.

I am a patient

This section provides information to support patients that have been prescribed Cabometyx® (cabozantinib) in Ireland. It is designed for patients in Ireland and should not replace the opinion provided by your healthcare professional or the details contained in the Patient Information Leaflet.

I am a patient

I am a member of the general public

This section is for members of the general public.

I am a member of the general public

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to the HPRA. Reporting forms and information can be found at www.hpra.ie or email medsafety@hpra.ie. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256. By reporting side effects, you can help provide more information on the safety of this medicine.